Laura Bogart
ID:
|
GAME CHANGERS: A PILOT INTERVENTION TO EMPOWER HIV CLIENTS AS PREVENTION ADVOCATES IN UGANDA (PHASE 2)
REFNo: SS166ES
Primary objectives include: Assessing preliminary intervention effects on:
a) protective behavior of the HIV-positive clients (condom use, partner concurrency/number of partners, engagement in HIV care, ART adherence)
b) diffusion of prevention messages across the network, as assessed by the content and extent of communication with network members about protective behaviors (condom use, partner concurrency/number of partners, HIV testing, engagement in HIV care, circumcision), HIV disclosure, and HIV stigma
|
USA |
2018-04-11 |
2021-04-11 |
Social Science and Humanities |
|
Non-degree Award |
|
CHARLES LUGERO
ID:
|
A global registry to study the demographics, socioeconomic and clinical factors, etiologies, pathophysiology, management, barriers to care, and outcomes of heart failure patients
REFNo: HS144ES
Study 1. Estimate the incident rate of outcomes in HF patients in world
Objectives regions and overall, and assess social and lifestyle factors
(demographics, socioeconomic variables, clinical risk factors, diet,
medication use, and health‐related quality of life), etiologies and
variations in treatment patterns that might influence mortality and
morbidity.
2. Describe determinants of different HF phenotypes (HFpEF, HFrEF,
HF due to valvular disease, ALVD) in these world regions, and their
management and outcomes.
G‐CHF Protocol Page 3 2016‐09‐26
Version 1.2
3. Describe the potential role of biomarkers (BNP/NT‐proBNP and
troponin, as available), related genetic determinants, and their
relation to clinical factors, treatments, and type of HF
4. Assess non‐cardiac co‐morbidities at enrolment, their incidence
during the study and how they influence outcomes from both
cardiovascular and non‐cardiovascular mortality and morbidity.
5. In a sub‐study of approximately 4000‐5000 patients, perform
measures of frailty, cognitive and lung function, mental health,
adherence to medication, and dietary assessment, with collection of
blood and urine samples for central analysis, to further understand
the pathophysiologic changes in HF and their relation to outcomes.
6. Describe patient and system barriers to HF care in a global HF
population.
|
Uganda |
2018-04-04 |
2021-04-04 |
Medical and Health Sciences |
|
Non-degree Award |
|
Clémence Bonneaud
ID:
|
Pant-hoot call in immature chimpanzees
REFNo: NS40ES
We will describe the age at which pant-hoot production starts. We will examine the order in which the four phases of the pant-hoot call develop. For example: is development sequential with the order of the final pant-hoot call, or do later phases (the climax) develop before early ones. We will investigate at what point multiple elements are produced within a call, and whether the sex differences seen in the pant-hoot calls of adults are also seen during development.
|
France |
2018-04-04 |
2021-04-04 |
Natural Sciences |
|
Degree Award |
|
Catriona Waitt John
ID: UNCST-2019-R001068
|
Clinical and genetic factors influencing variability in warfarin dose requirements in Sub-Saharan African patients: An observational study
REFNo: HS164ES
1. To determine demographic and clinical factors that determine individual daily dose requirements for warfarin in Ugandan and South African patients receiving warfarin as part of their routine care
2. To identify ethnic-specific genetic factors influencing individual daily dose requirements for warfarin in Ugandan and South African patients receiving warfarin as part of their routine care
|
UK |
2018-04-04 |
2021-04-04 |
Medical and Health Sciences |
|
Non-degree Award |
|
Agnes Kiragga
ID:
|
Locating disengaged HIV positive women on Option B+ and ascertainment of outcomes among their infants
REFNo: HS175ES
1. To describe the pregnancy outcomes and HIV care status among women (and their exposed infants) who initiate Option B+
2. To correct 6 week and 18 month estimates of MTCT through tracing of a random sample of HIV positive women who initiated Option B+ during pregnancy and disengaged from care.
3. To identify factors associated with HIV sero-positivity among infants born to women initiated on Option B+.
4. To establish the frequency of Multiclass Resistance among HIV positive infants born to women initiated on Option B+
5. To estimate the proportion of disengaged women with viral failure and correct estimates of viral suppression (3 rd UN 90 goal) in the facilities.
|
Uganda |
2018-04-04 |
2021-04-04 |
Medical and Health Sciences |
|
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|